PlainRecalls
FDA Drug Low Class III Terminated

Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10

Reported: July 22, 2020 Initiated: July 13, 2020 #D-1391-2020

Product Description

Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10

Reason for Recall

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
63,067 vials
Distribution
Nationwide within the United States
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10. Recalled by Fresenius Kabi USA, LLC. Units affected: 63,067 vials.
Why was this product recalled?
Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 22, 2020. Severity: Low. Recall number: D-1391-2020.